Comparison of Janus kinase inhibitors to block the type I interferon pathway in human skeletal muscle cells
This study compares the effectiveness of 48 JAK inhibitors in blocking the JAK1/TYK2-dependent type I interferon-MHC class I pathway in human skeletal muscle cells.
bioRxiv · Feb 8, 2021 · PreprintImmunology